Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
European Respiratory Society (ERS)/ European Society for Blood and Marrow Transplantation (EBMT) clinical practice guidelines on treatment of pulmonary cGvHD in adults

European Respiratory Society (ERS)/ European Society for Blood and Marrow Transplantation (EBMT) clinical practice guidelines on treatment of pulmonary cGvHD in adults

RSV Burden in Infants

RSV Burden in Infants

Saudi initiatives on Bronchiolitis Recommendations

Saudi initiatives on Bronchiolitis Recommendations

Airway Hyperresponsiveness<br/>in Asthma

Airway Hyperresponsiveness
in Asthma

Atopic Dermatitis Pathophysiology: Breaking Down the Barrier

Atopic Dermatitis Pathophysiology: Breaking Down the Barrier

Importance of assessing key disease domains in EOE

Importance of assessing key disease domains in EOE

Daily Burden of CRSwNP

Daily Burden of CRSwNP

EOE Pediatric - Unmasking the Hidden Symptoms

EOE Pediatric - Unmasking the Hidden Symptoms

Uncover ASMD and GAUCHER

Uncover ASMD and GAUCHER

Approach for Patients with PAD and T2D: Focus on LDL-C Control

Approach for Patients with PAD and T2D: Focus on LDL-C Control

Approach for Patients with CAD: Focus on LDL-C Control

Approach for Patients with CAD: Focus on LDL-C Control

Cardiovascular diseases (CVDs) are the leading cause of death globally<sup>1</sup>

Cardiovascular diseases (CVDs) are the leading cause of death globally1

According to the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths1. Of these deaths, 85% were due to myocardial infarction or stroke1.

A CV event is a highly traumatic experience for patients and their families2. It takes a heavy emotional toll, brings widespread disability and significantly impedes quality of life3,4.